In this excerpt, Dr. Natalie Marshall focuses on high intensity interval training, or HIIT. Dr. Marshall discusses the health benefits of HIIT which can be achieved in a short amount of time. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 41186]

Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), is a noninvasive treatment using sound waves to address essential tremor and tremor-dominant Parkinson’s disease. Drs. Doris Wang and Leo Sugrue of UCSF explain how FUS and deep brain stimulation work to reduce tremor, outline which patients may benefit, and describe how the UCSF team individualizes treatment. Series: "UC San Francisco News" [Health and Medicine] [Show ID: 41035]

Founded in 1975, UCSF Fresno commemorates 50 remarkable years of training local doctors and improving healthcare in California's Central Valley in 2025. UCSF Fresno is a regional campus of UCSF's School of Medicine, located in the heart of California's San Joaquin Valley. By both serving and drawing strength from extraordinarily deep community roots, UCSF Fresno brings critical health care to families while to growing the next generation of health care providers and researchers. [Health and Medicine] [Show ID: 40987]

Urinary incontinence and sexual dysfunction are common side effects of prostate cancer treatment, but both are manageable. Dr. Lindsay Hampson explains the types of incontinence—stress, urge, mixed, and overflow—and how identifying the cause guides treatment. Management strategies include pelvic floor physical therapy, medications, and surgical options like slings or artificial urinary sphincters. For sexual dysfunction, approaches range from oral medications and vacuum devices to injections and implants. Dr. Michael Rabow also highlights the side effects of androgen deprivation therapy, including fatigue, depression, hot flashes, and cardiovascular risk. He outlines evidence-based strategies—like exercise, cognitive behavioral therapy, and medications—to help preserve well-being and quality of life during treatment. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40869]

Dr. Rahul Aggarwal presents emerging treatments for advanced prostate cancer, highlighting rapid advances in drug development. He outlines therapies targeting cancer cell surface proteins beyond PSMA, including CD46, B7-H3, and DLL3, and explains how antibody-drug conjugates deliver potent chemotherapy directly to tumors. He also discusses bispecific T-cell engagers designed to trigger immune attacks on cancer cells, including promising results from agents like Talquetamab. Aggarwal explores new isotopes such as actinium-225 for radioligand therapy, which may offer stronger and more durable responses than current treatments. He emphasizes continued innovation in targeting the androgen receptor, with drugs that degrade the receptor or block androgen production more effectively than existing therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40813]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Neurosurgeons at UCSF, led by Drs. Edward Chang and Anthony Lee, present a “contactless” microvascular decompression (MVD) approach for trigeminal neuralgia using a pericranium sling. This technique repositions the offending blood vessel with the patient’s own pericranial tissue, avoiding synthetic materials like Teflon. By eliminating foreign implants, it reduces risks of inflammation, granuloma formation, persistent nerve compression, and implant movement. These doctors report that transposition techniques using either pericranium or Teflon slings may provide more durable pain relief than interposition methods. However, all MVD approaches studied significantly reduced pain for patients with this debilitating condition, offering safer and potentially longer-lasting outcomes. Series: "UC San Francisco News" [Health and Medicine] [Show ID: 41038]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

UCSF stroke neurologist Dr. Anirudh Sreekrishnan and UCSF vascular neurosurgeon Dr. Luis Savastano describe Moyamoya disease, a rare condition where arteries at the base of the brain become narrowed or blocked, reducing blood flow. The name “moyamoya” means “puff of smoke” in Japanese, describing the tiny vessels that form to compensate. These fragile vessels can cause strokes or bleeding. Treatment often involves surgical procedures, such as direct or indirect revascularization, to restore blood flow and reduce stroke risk. Series: "UC San Francisco News" [Health and Medicine] [Show ID: 41036]

Experts present new tools for managing PSA-recurrent prostate cancer. Dr. Steven Seyedin describes how PET/CT imaging enhances detection by reducing false positives and improving staging accuracy. Dr. Thomas Hope highlights PSMA PET imaging, now the standard approach, which identifies cancer more precisely by targeting tumor-specific proteins. Dr. Julian Hong discusses stereotactic body radiation therapy (SBRT) for patients with limited metastases, showing that it offers effective, low-toxicity treatment while preserving quality of life. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40867]